Search

Your search keyword '"Chigiotti, S"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Chigiotti, S" Remove constraint Author: "Chigiotti, S"
23 results on '"Chigiotti, S"'

Search Results

1. High SVR rates with SMV+SOF in HCV GT1 and GT4 patients with cirrhosis or advanced fibrosis: A real practice analysis from a large regional database in Tuscany, Italy

2. High SVR Rates with SMV + SOF in HCV GT1 and GT4 Patients with Cirrhosis or Advanced Fibrosis: A Real Practice Analysis from a Large Regional Database in Tuscany, Italy

3. Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis

4. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

5. A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loads

6. Economic evaluation of HIV treatments: The I.CO.N.A. cohort study

7. SAT-144 - High SVR Rates with SMV + SOF in HCV GT1 and GT4 Patients with Cirrhosis or Advanced Fibrosis: A Real Practice Analysis from a Large Regional Database in Tuscany, Italy

9. Evolution of HVR-1 Quasispecies after 1-Year Treatment in HIV/HCV-Coinfected Patients According to the Pattern of Response to Highly Active Antiretroviral Therapy

10. Response to Haart and Gb Virus Type C Coinfection in a Cohort of Antiretroviral-Naive HIV-Infected Individuals

11. The Management of Hepatitis B Virus/HIV-1 Co-Infected Patients Starting Their First Haart Regimen. Treating Two Infections for the Price of One Drug?

12. Variability in the Interpretation of Transmitted Genotypic HIV-1 Drug Resistance and Prediction of Virological Outcomes of the Initial Haart by Distinct Systems

13. Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART

14. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

15. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1 infected individuals with virological failure to all three antiretroviral-drug classes

16. Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID-19 pandemic.

17. Spontaneous abdominal bleeding associated with SARS-CoV-2 infection: causality or coincidence?

18. Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany.

19. Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study.

20. Pharmacokinetic and safety of raltegravir in pregnancy.

21. Mesalazine-induced multi-organ hypersensitivity.

22. Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAART.

23. Susceptibility of macrolide and beta-lactam antibiotics of Streptococcus pyogenes strains isolated over a four-year period in central Italy.

Catalog

Books, media, physical & digital resources